Test Price
2,800 AED✅ Home Collection Available
EIF2B5 Gene Leukoencephalopathy with Vanishing White Matter Genetic Test in UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited NGS processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Whole Blood, FTA Card, or Extracted DNA). Available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation included.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The EIF2B5 Gene Leukoencephalopathy with Vanishing White Matter Genetic Test detects pathogenic mutations in the EIF2B5 gene linked to Vanishing White Matter (VWM) disease, a severe neurological leukodystrophy. This advanced test utilises Next‑Generation Sequencing for comprehensive variant analysis and is processed in our DHA‑licensed, ISO 9001:2015 facility for results you can trust.
| Feature | Our NGS Test (EIF2B5) | Closest Alternative (Single‑Gene Sanger Sequencing) |
|---|---|---|
| Precision | Full exon coverage, detection of SNVs, indels, copy number changes | Targeted known mutations only; limited variant discovery |
| Methodology | NGS (Next Generation Sequencing) on Illumina platform, validated bioinformatics | Sanger chain‑termination sequencing |
| Turnaround Time | 3 to 4 weeks | 4 to 6 weeks (often slower due to manual analysis) |
Physician Insight & Safety Protocols
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Notice
Medication Warning
Do not discontinue any prescribed medication without direct consultation with your treating physician. This genetic test is for diagnostic use only and does not replace ongoing medical management.
Exclusion Criteria & ER Red Flags
- Inability to give informed consent or lack of legal guardian consent for minors (as per Federal Decree-Law No. 4 of 2016 on Medical Liability).
- Acute febrile illness or severe infection that could compromise sample quality.
- Known coagulopathy or bleeding disorder unless medically cleared for venipuncture.
- If the patient is experiencing acute neurological deterioration, seek immediate emergency care; testing is not a substitute for emergency evaluation.
Patient FAQ & Clinical Guidance
1. How accurate is the EIF2B5 Genetic Test for Vanishing White Matter disease?
Our NGS test delivers greater than 99.9% analytical sensitivity and specificity for detecting single nucleotide variants, small insertions/deletions, and copy number changes in the EIF2B5 gene, validated against clinical reference standards.
2. What sample types are accepted and how is the collection performed?
A simple venous blood sample (EDTA whole blood) or a dried blood spot on an FTA card is collected by a licensed home-care phlebotomist; alternatively, previously extracted DNA can be submitted using our cold‑chain logistics. VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection is available daily from 8 AM to 11 PM.
3. How long does it take to receive results and who will explain them?
Turnaround time is 3 to 4 weeks; a telephonic post-test consultation with a genetic counsellor or neurologist is included to interpret findings, discuss implications, and plan next steps.
UAE Regulatory & Data Privacy Adherence
This test is conducted in full compliance with UAE federal laws governing health data and patient privacy:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – ensuring secure handling of your genomic and personal data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – governing electronic health records and telemedicine practices.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – establishing standards for informed consent and clinical responsibility.
Clinical & Logistical Metadata
| Test Name | EIF2B5 Gene Leukoencephalopathy with Vanishing White Matter Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3 to 4 weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA), dried blood spot (FTA card), or extracted DNA |
| Methodology Used | Next-Generation Sequencing (NGS) on Illumina platform with validated bioinformatics pipeline |
| ICD-10-CM Code | G31.89 |
| LOINC Code | 81247-9 |
| DHA Facility License & Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians